Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Laif 900 is a herbal medicinal product containing St. John's wort dry extract, primarily used for treating mild to moderate depressive episodes. Each film-coated tablet contains 900 mg of St. John's wort dry extract, which corresponds to approximately 4 g of St. John's wort herb. ## Mechanism of Action Laif 900 works by re-establishing the balance of neurotransmitters in the brain that are responsible for mood, drive, and sleep regulation[1][5]. Depression is often associated with an imbalance of these neurotransmitters, and St. John's wort helps regulate them, particularly those involved in mood regulation[5]. Additionally, it normalizes the increased distribution of the stress hormone cortisol that occurs with excessive stress[5]. ## Usage and Dosage The recommended dosage is one film-coated tablet per day, taken in the morning after breakfast[1][2]. Unlike pain medications, Laif 900 does not work immediately but requires time to build up its full effect. Patients typically experience noticeable improvement within 4 weeks[1]. For optimal results, it's recommended to continue taking the medication for several weeks, even after symptoms have subsided[5]. ## Benefits - Promotes balance of body and soul - Helps with lack of drive, inner unrest, and mental sleep disorders - Has a mood-lifting and balancing effect - Easy intake: only once daily - Non-habit forming and doesn't cause daytime drowsiness[5] ## Safety Profile The clinical safety data indicates that the frequency and severity of adverse effects are lower than those of standard antidepressants[3]. However, there are important safety considerations, particularly regarding drug interactions. Laif 900 interacts with medications metabolized by liver enzymes (CYP3A4, CYP2C9, CYP2C19) and P-glycoprotein[3]. ## Contraindications Laif 900 should not be used concurrently with: - Immunosuppressants (ciclosporin, tacrolimus, sirolimus) - HIV medications (indinavir, nevirapin) - Certain cancer medications (imatinib, irinotecan) - In cases of known allergy to St. John's wort or any other ingredients[6] ## Special Considerations - Not recommended during pregnancy and breastfeeding without medical consultation - Not recommended for children under 12 years - May cause increased photosensitivity (sunburn-like reactions when exposed to strong sunlight)[2] - Should be used under medical supervision if symptoms persist beyond 4 weeks[2] Laif 900 is a prescription medication in some countries due to its potential for interactions with other medications[3]. It's suitable for vegans and is free of gluten and lactose[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Laif 900.